ProPhase Labs, Inc. (PRPH)
OTCMKTS · Delayed Price · Currency is USD
0.0158
+0.0038 (31.67%)
At close: Oct 2, 2026
ProPhase Labs Market Cap
ProPhase Labs has a market cap or net worth of $246.36 thousand as of October 2, 2026. Its market cap has decreased by -98.85% in one year.
Market Cap
246.36K
Enterprise Value
9.35M
Revenue
3.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
ChartMarket Cap Chart
Since January 2, 1996, ProPhase Labs's market cap has decreased from 5.04M to 246.36K, a decrease of -95.11%. That is a compound annual growth rate of -9.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 246.36K | -88.08% |
| Dec 31, 2025 | 2.07M | -88.57% |
| Dec 31, 2024 | 18.08M | -77.84% |
| Dec 29, 2023 | 81.56M | -47.97% |
| Dec 30, 2022 | 156.75M | 41.18% |
| Dec 31, 2021 | 111.03M | 4.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| iMD Companies | 2.54M |
| Stella Diagnostics | 2.43M |
| IDenta | 1.35M |
| InVitro International | 1.34M |
| Hypha Labs | 712.95K |
| NovelStem International | 468.66K |
| Medical Imaging | 63.82K |
| T2 Biosystems | 14.02K |